» Articles » PMID: 26098216

Mature T Cell Responses Are Controlled by MicroRNA-142

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2015 Jun 23
PMID 26098216
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

T cell proliferation is critical for immune responses; however, the molecular mechanisms that mediate the proliferative response are poorly understood. MicroRNAs (miRs) regulate various molecular processes, including development and function of the immune system. Here, utilizing multiple complementary genetic and molecular approaches, we investigated the contribution of a hematopoietic-specific miR, miR-142, in regulating T cell responses. T cell development was not affected in animals with a targeted deletion of Mir142; however, T cell proliferation was markedly reduced following stimulation both in vitro and in multiple murine models of graft-versus-host disease (GVHD). miR-142-deficient T cells demonstrated substantial cell-cycling defects, and microarray and bioinformatics analyses revealed upregulation of genes involved in cell cycling. Moreover, 2 predicted miR-142 target genes, the atypical E2F transcription factors E2f7 and E2f8, were most highly upregulated in miR-142-deficient cells. Clustered regularly interspaced short palindromic repeat interference-mediated (CRISPRi-mediated) silencing of E2F7 and E2F8 in miR-142-deficient T cells ameliorated cell-cycling defects and reduced GVHD, and overexpression of these factors in WT T cells inhibited the proliferative response. Together, these results identify a link between hematopoietic-specific miR-142 and atypical E2F transcription factors in the regulation of mature T cell cycling and suggest that targeting this interaction may be relevant for mitigating GVHD.

Citing Articles

miR-142 deficit in T cells during blast crisis promotes chronic myeloid leukemia immune escape.

Chen F, Zhao D, Xu Y, Zhang Y, Chen M, Pathak K Nat Commun. 2025; 16(1):1253.

PMID: 39893171 PMC: 11787332. DOI: 10.1038/s41467-025-56383-y.


MicroRNA-142 regulates gut associated lymphoid tissues and group 3 innate lymphoid cells.

Roberts L, Neves J, Lee D, Valpione S, Tacho-Pinot R, Howard J Mucosal Immunol. 2024; 18(1):39-52.

PMID: 39245145 PMC: 11835792. DOI: 10.1016/j.mucimm.2024.09.001.


MicroRNA expression signature as a biomarker in the diagnosis of nodal T-cell lymphomas.

Bin Masroni M, Ling Eng G, Jeon A, Gao Y, Cheng H, Leong S Cancer Cell Int. 2024; 24(1):48.

PMID: 38291429 PMC: 10826179. DOI: 10.1186/s12935-024-03226-3.


miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities.

Huang W, Paul D, Calin G, Bayraktar R Cells. 2024; 13(1).

PMID: 38201290 PMC: 10778542. DOI: 10.3390/cells13010084.


A panel of blood-based circulatory miRNAs with diagnostic potential in patients with psoriasis.

Madaan P, Sharma U, Tyagi N, Brar B, Bansal S, Kushwaha H Front Med (Lausanne). 2023; 10:1207993.

PMID: 37700769 PMC: 10493330. DOI: 10.3389/fmed.2023.1207993.


References
1.
Sun Y, Tawara I, Zhao M, Qin Z, Toubai T, Mathewson N . Allogeneic T cell responses are regulated by a specific miRNA-mRNA network. J Clin Invest. 2013; 123(11):4739-54. PMC: 3809794. DOI: 10.1172/JCI70013. View

2.
Chen B, Gilbert L, Cimini B, Schnitzbauer J, Zhang W, Li G . Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell. 2013; 155(7):1479-91. PMC: 3918502. DOI: 10.1016/j.cell.2013.12.001. View

3.
Wallner B, Mattaliano R, Hession C, Cate R, Tizard R, Sinclair L . Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature. 1986; 320(6057):77-81. DOI: 10.1038/320077a0. View

4.
Li J, Ran C, Li E, Gordon F, Comstock G, Siddiqui H . Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Dev Cell. 2008; 14(1):62-75. PMC: 2253677. DOI: 10.1016/j.devcel.2007.10.017. View

5.
Mathew J, Taylor B, Bader G, Pyarajan S, Antoniotti M, Chinnaiyan A . From bytes to bedside: data integration and computational biology for translational cancer research. PLoS Comput Biol. 2007; 3(2):e12. PMC: 1808026. DOI: 10.1371/journal.pcbi.0030012. View